1. imaging agent which comprises a compound of Formula I: wherein: LBP represents lantibiotichesky peptide of Formula II: Xaa is Arg or Lys Cys-Thr, Ser-Cysi Cys-Thrkovalentno connected via thioether bonds Ser-Lyskovalentno connected via communication lizinoalaninovoy HO-Asp represents β-gidroksiasparaginovuyu acid Z- (L) - attached to CysLBP or when Xaa represents Lys, Xaa Cysili to where Zsoderzhit metallaTc radioactive complex with a chelating agent having at least 4 donor atoms to the metal wherein at it least 4 of said donor atoms to the metal in said metal complex bound radioactive sTc Zprisoedinen to the C-terminus of LBP and represents OH, OBili M, where Bpredstavlyaet a biocompatible cation iMpredstavlyaet a group of inhibiting the metabolism of which is a biocompatible group, inhibitory or inhibitory peptide metabolism LBP in vivo L is a synthetic linker group of formula - (A) -, wherein each A independently represents-CR-, -CR = CR-, -C≡C-, -CRCO-, -COCR-, -NRCO-, -CONR-, -NR (C = O) NR-, -NR (C = S) NR-, -SONR-, -NRSO-, -CROCR-, -CRSCR-, -CRNRCR-, Stsiklogeteroalkilenovuyu group Stsikloalkilenovuyu group Sarilenovuyu group or Sgeteroarilenovuyu group, an amino acid, a sugar or a monodisperse polyethyleneglycol (PEG) building block each R independently you wounds of H, alkyl, alkenyl, alkynyl, or Salkoksialkila Sgidroksialkila m represents an integer with a value from 1 to 20 n represents an integer with value 0 or 1.2. Imaging agent according to claim 1, wherein the chelating agent is a tetradentate chelator having nabor.3 N4-donor. Imaging agent of claim 2, wherein N4-1. Визуализирующий агент, который содержит соединение Формулы I:где:LBP представляет собой лантибиотический пептид Формулы II:Хаа представляет собой Arg или LysCys-Thr, Ser-Cysи Cys-Thrковалентно соединены посредством тиоэфирных связейSer-Lysковалентно соединены посредством лизиноаланиновой связиHO-Asp представляет собой β-гидроксиаспарагиновую кислотуZ-(L)- присоединен к CysLBP или, когд
